TG Therapeutics Inc
F:NKB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TG Therapeutics Inc
F:NKB2
|
US |
|
Batliboi Ltd
NSE:BATLIBOI
|
IN |
|
Good Flour Corp
OTC:GFCOF
|
CA |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
|
New Zealand Oil and Gas Ltd
ASX:ECH
|
NZ |
|
A
|
Arrail Group Ltd
F:I1D
|
CN |
|
F
|
Friwo AG
F:CEA
|
DE |
|
C
|
Chugai Pharmaceutical Co Ltd
F:CUP
|
JP |
|
N
|
Ningbo Shanshan Co Ltd
F:OJ8
|
CN |
|
Athersys Inc
F:4LSA
|
US |
|
F
|
Friwo AG
XMUN:CEA
|
DE |
|
Gold Resource Corp
XTSX:GORO
|
US |
|
F
|
Friwo AG
DUS:CEA
|
DE |
|
N
|
Nagacorp Ltd
XMUN:N9J
|
KH |
|
F
|
Friwo AG
XBER:CEA
|
DE |
|
A
|
Athersys Inc
F:4LS
|
US |
|
C
|
China Suntien Green Energy Corp Ltd
F:9C6
|
CN |
|
C
|
Chugai Pharmaceutical Co Ltd
XBER:CUP
|
JP |
|
N
|
Nagacorp Ltd
OTC:NGCRY
|
KH |
Shareholder Yield
Current shareholder yield for 
NKB2 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NKB2 Price
TG Therapeutics Inc
| Average Annual Return | 15.93% |
| Standard Deviation of Annual Returns | 61.83% |
| Max Drawdown | -89% |
| Market Capitalization | 8.5B EUR |
| Shares Outstanding | 154 540 000 |
| Percentage of Shares Shorted |
N/A
|
